Vaccine against Ebola: Commission grants first-ever market authorisation

ebola news.jpg

Finnish Red Cross/Maria Santto Rinsing Ebola protective gear in Beni, Democratic Republic of the Congo.

This article is brought to you in association with the European Commission.


Today, the European Commission adopted the decision granting marketing authorisation to the company Merck Sharp & Dohme B.V. for a vaccine against Ebola. This vaccine, called Ervebo, had been in development since the Ebola outbreak in West Africa in 2014. It is already used, as part of a specific protocol, to protect people at risk of infection, such as healthcare workers or people who have been exposed to infected persons.

This decision follows the recommendation from the European Medicines Agency (EMA), which has assessed the benefits and risks of the vaccine. It also follows the recent announcement of a clinical trial for a second Ebola vaccine regimen (Ad26.ZEBOV, MVA-BN-Filo) that is now under way in the Democratic Republic of Congo, with the support of the EU’s research and innovation programme Horizon 2020.

Vytenis Andriukaitis, Commissioner in charge of Health and Food Safety, said: “Finding a vaccine as soon as possible against this terrible virus has been a priority for the international community ever since Ebola hit West Africa five years ago. Today’s decision is therefore a major step forward in saving lives in Africa and beyond.”

Christos Stylianides, Commissioner for Humanitarian Aid and Crisis Management and EU Ebola Coordinator, said: “The EU is supporting international efforts to combat Ebola on all fronts, from vaccine development to delivering humanitarian aid on the ground. We will continue assisting the fight to tackle epidemic for as long as it takes.”

The clinical development of Ervebo was launched during the outbreak in West Africa five years ago. It was made possible through cooperation with public health stakeholders, which include national institutes of health, ministries of health in Africa (notably in Sierra Leone, Liberia, and Guinea), as well as the WHO, the Norwegian Institute of Public Health and Médecins Sans Frontières (MSF).

The development of the vaccine was supported by two projects from the Innovative Medicines Initiative (IMI) funded by the EU’s research and innovation programme Horizon 2020:

  • VSV-EBOVAC (March 2015-Feb. 2019), led by Academisch Ziekenhuis Leiden (NL) with €3.9 million EU contribution,
  • VSV-EBOPLUS (April 2016-March 2021), led by Merck Sharp & Dohme, with €8.5 million EU contribution.

Background

Ebola is a rare but severe illness caused by a virus of the same name. Death rates in patients who have contracted the disease have varied from 25% to 90% in past outbreaks. The largest outbreak to date occurred in West Africa in 2014-2016 with more than 11 000 deaths. The current outbreak in the Democratic Republic of Congo (DRC), caused by Ebola Zaire, has shown case fatality rates of approximately 67%. More than 3 000 people have been infected with the Ebola virus during the ongoing outbreak, which was declared a public health emergency of international concern by the World Health Organization (WHO) in July 2019. WHO extended this decision for another three months in October 2019.

The authorisation of a medicine under the centralised procedure is a two-stage process, involving the European Medicines Agency (EMA) and the European Commission.

EMA assesses the benefits and risks of medicines and makes recommendations to the Commission, which then takes a final legally binding decision on whether or not the medicine can be marketed in the EU.

This decision is issued normally within 67 days (legal deadline) of the scientific opinion of EMA (for Ervebo the date was 17 October). This phase includes, among other things, the translation of the product guidelines in all EU languages and a consultation with Member States (Comitology). In view of the public health interest, the Commission has accelerated this process and authorised the medicine in less than a month, in other words cutting the decision-making process in half.

The assessment report for Ervebo will be published on EMA’s website.

Moreover, the EU is part of the Innovative Medicines Initiative (IMI), a public-private partnership, which has supported the clinical development of the investigational preventive Ebola vaccines, as well as diagnostic tests through the IMI Ebola+ call.

Advertising

the sting Milestone

Featured Stings

Can we feed everyone without unleashing disaster? Read on

These campaigners want to give a quarter of the UK back to nature

How to build a more resilient and inclusive global system

Stopping antimicrobial resistance would cost just USD 2 per person a year

China, forever new adventures

How scientists are turning living cells into the tiny factories of the future

NEC @ MWC14: “Smart cities” hold the key to enhancing citizens’ lives and cutting costs

Trump-China trade war lingers upsetting global economy and stock markets

UN gender agency hails record-breaking number of women in new US Congress as ‘historic victory’

Telecommunications and Internet: A Jungle with no principles?

Why your next work meeting should be a ‘walk-and-talk’

From Policy to Reality: Discrepancies in Universal Health Care Systems across the EU

OECD welcomes French plans to increase and better target foreign aid

Towards a tobacco free India

Does the Greek deal strengthen the Eurozone? Markets react cautiously

UN agency chiefs issue ‘call to action’ on behalf of refugee children

UN global education envoy urges new funding for ‘lost generation’ of children forced out of classrooms by conflict

EU-US ties to break over Iran; Democrats’ electoral win may not change it

Greening the Belt and Road is essential to our climate’s future

Europe bewildered by radicalisation and terrorism

Here’s how China is going green

MEPs vote to limit negative impact of no-deal Brexit on citizens

Europe divided: 30 years on from the fall of the Berlin Wall

State aid: Commission adopts Temporary Framework to enable Member States to further support the economy in the COVID-19 outbreak

Why law enforcement and businesses need to join forces to fight global cybercrime

Antitrust: Commission fines Google €4.34 billion for illegal practices regarding Android mobile devices to strengthen dominance of Google’s search engine

Will Europe be able to deal with the migration crisis alone if Turkey quits the pact?

UN spotlights digitization of audiovisual archives to preserve human history on World Day

Minority governments ‘à la mode’ in Europe but can they last long?

Why we need different generations in the workplace

Budget MEPs approve €104.2 m in EU aid to Greece, Spain, France and Portugal

Facility for Refugees in Turkey: €127 million to boost EU’s largest ever humanitarian programme

While EU Open Days 2013 discuss the 2020 strategy, Microsoft shares a glimpse of EU 2060

‘12 million’ stateless people globally, warns UNHCR chief in call to States for decisive action

MasterCard at European Business Summit 2015: A focus on innovation will drive inclusive economic growth for Europe

State aid: Commission approves UK schemes to support SMEs affected by coronavirus outbreak

Medical workforce migration in Europe – Is it really a problem?

European Commission adopts new list of third countries with weak anti-money laundering and terrorist financing regimes

How businesses can create an ethical culture in the age of tech

This one small change could transform education for millions

Refugee crisis update: EU lacks solidarity as migration figures drop

Britain heading to national schism on exit from EU

Bioethics: how to recover trust in the doctor-patient relationship

Coronavirus vs flu: how do they compare?

DR Congo: Ebola outbreak spreads to eastern ‘no-go’ zone surrounded by rebels

MEPs back plans to promote water reuse for agricultural irrigation

How wealthy people transmit this advantage to their children and grand children

Rise in violent conflict shows prevention ‘more necessary than ever’: UN chief

Fairness should be at the heart of the agricultural goods trade

Services are the hidden side of the US-China trade war

How to help companies become global defenders of LGBTI rights

The banks dragged Eurozone down to fiscal abyss

Raw materials: Commission launches new online portal to support responsible sourcing in businesses

Mergers: Commission approves acquisition of L3 Technologies by Harris Corporation, subject to conditions

UN chief welcomes Taliban’s temporary truce announcement, encourages all parties to embrace ‘Afghan-owned peace’

Commission presents EU-Vietnam trade and investment agreements for signature and conclusion

How the coronavirus market turmoil compares to 2008 – and what we can do

Parliament’s interparliamentary delegations established

Why do overwhelming proportions of EU’s youth feel excluded?

UN chief welcomes prisoner exchange between the Russia and Ukraine

‘No other possibility but to leave’: UN News special report from the Nigeria-Cameroon border as 35,000 newly-displaced seek safety

De-escalation of fighting in Hodeida is key to ‘long-overdue’ restart of Yemen peace talks: UN envoy

A new way to teach active citizenship to students?

Why the world is not as globalized as you think

More Stings?

Advertising

Speak your Mind Here

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out /  Change )

Google photo

You are commenting using your Google account. Log Out /  Change )

Twitter picture

You are commenting using your Twitter account. Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. Log Out /  Change )

Connecting to %s